Amneal unveils dexamethasone
BRIDGEWATER, N.J. — Amneal Pharmaceuticals announced on Wednesday that it is launching dexamethasone, 4mg and 6 mg, following Abbreviated New Drug Application (ANDA) approval from the U.S. Food and Drug Administration. Dexamethasone, the generic version of Decadron, is a well-established anti-inflammatory glucocorticoid steroid used to treat several medical conditions, including respiratory complications associated with COVID-19.
